10 Trending Stocks This Week
The massive AI deals and capital spending plans announced by some of the top technology companies have stunned many on Wall Street, fueling concerns that we may be living through an AI bubble or caught...
Merck Sharp & Dohme Corp. (MRK)
This company is not actively trading or the ticker does belong to another company in our database now. The symbol (MRK) is currently associated with the following stock: Merck & Co. Inc. (MRK)
Sector: Pharmaceutical Preparations
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $33.22 | 550 | $18,268.75 | 750 | 2006-01-18 | Filing | |
| $45.65 | 200 | $9,130.56 | 200 | 2002-09-24 | Filing |
News See All
11 Defensive Healthcare Dividend Stocks To Buy Now
US healthcare stocks have been under mounting pressure this year, largely due to policies introduced by the Trump administration.
13 Best Forever Stocks to Invest In Now
On October 11, Tom Lee from Fundstrat appeared on CNBC Television to discuss the recent market decline, as the S&P 500 dropped by around 2.9% on Friday, October 10.
Merck Completes $10B Acquisition of Verona Pharma, Adds COPD Drug Ohtuvayre
Merck & Co. Inc. (NYSE:MRK) is one of the best growth stocks to buy now. On October 7, Merck & Co. announced the completion of its acquisition of Verona Pharma (NASDAQ:VRNA).
Merck Initiates Three New Phase 2b Trials for Investigational Inflammatory Drug Tulisokibart
Merck & Co. Inc. (NYSE:MRK) is one of the most promising stocks under $100. On October 6, Merck & Co. announced the initiation of three new Phase 2b trials for tulisokibart (MK-7240).
12 Best Growth Stocks to Buy Now
On October 1, Keith Lerner, Chief Investment Officer at Truist Wealth, appeared on CNBC and stated that the shutdown fears are muted, and investors are not overly concerned right now.
14 Most Promising Stocks Under $100
On October 10, Tom Lee of Fundstrat joined 'Closing Bell' on CNBC to suggest that the S&P can still get to at least 7,000 this year. Tom Lee stated that markets are attempting to balance a few things.
Chart Expert Says Merck (MRK) Has More Upside - Here’s Why
Carter Worth from Worth Charting said in a latest program on CNBC that Merck & Co Inc (NYSE:MRK) is one of the stocks that has more upside potential based on his analysis.
Why Merck & Co (MRK) Continues to Rank Among the Most Profitable Dividend Stocks
An American multinational pharmaceutical company, Merck & Co., Inc. (NYSE:MRK) is one of the most profitable stocks that pay dividends, with a trailing twelve-month net profit margin of 25.8%.
Hedge Fund Resource Center Billionaire Hedge Funds
